Spotlight
Partners
Nuzrya for CAPB or ABSSI
Nuzrya (omadacycline, Paratek®)
Indications: Adult patients with Counity-acquired bacterial pneumonia (CAPB) or acute bacterial skin and skin structure infections (ABSSI)
Dosage:
- CAPB
- Day 1: Intravenous infusion 200 mg/60 min or 100 mg/30 min (x2);
- Maintenance
- Intravenous Infusion: 100 mg / 30 min
- 300 mg orally once daily
- ABSSSI
- Day 1: Intravenous infusion 200 mg / 60 min or 100 mg/30 min (x2)
- Maintenance
- Intravenous Infusion: 100 mg/30 min
- 300 mg orally once daily
- Tablets
- Day 1&2: 250 mg orally once daily
- Maintanence: 300 mg orally once daily
Contraindications: Known hypersensitivity to omadacycline, tetracycline-class antibacterial drugs or any of the excipients in NUZYRA
Click here for morhttp://www.nuzyra.com/PI.pdfe prescribing information
Related Content
